NCT02167256: A trial that was reported late by Yale University
This trial has reported, although it was 112 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02167256 |
|---|---|
| Title | A Phase IIa Multi-Center Study of 18F-FDG PET, Safety, and Tolerability of AZD0530 in Mild Alzheimer's Disease |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Dec. 31, 2014 |
| Completion date | Feb. 27, 2018 |
| Required reporting date | Feb. 27, 2019, midnight |
| Actual reporting date | June 19, 2019 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 112 |